Contact this trialFirst, we need to learn more about you.
Bcl-2 Inhibitor
Sonrotoclax + Zanubrutinib for Blood Cancers
Recruiting1 awardPhase 1 & 2
Fort Wayne, Indiana
This trial aims to test new ways of giving sonrotoclax to patients with blood cancers to make sure it is safe for them to use.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.